Recent publications · Crossref
5 total works indexed
- Coherent Measures of Risk
· 1999 · cited 6,496x
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
· 2016 · cited 5,597x
- Graphene-based composites
· 2012 · cited 3,643x
- LSST: From Science Drivers to Reference Design and Anticipated Data Products
· 2019 · cited 3,303x
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial